GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

Clinical Science

Volumn 122, Issue 8, 2012, Pages 375-384

  Wu, Lin ^a   Olverling, Anna ^b   Huang, Zhen ^b   Jansson, Leif ^c   Chao, Hongfen ^a   Gao, Xin ^a   Sjöholm, Åke ^b  

^a FUDAN UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Exendin 4; Glycaemia; Insulin secretion; Pancreatic islet; Vasoactive effect

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; RADIOACTIVE MICROSPHERE; SODIUM CHLORIDE; INSULIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PEPTIDE; VENOM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; FEMORAL VEIN; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; IN VIVO STUDY; INSULIN RELEASE; ISLET BLOOD FLOW; KIDNEY BLOOD FLOW; MALE; MICROCIRCULATION; NERVE BLOCK; NONHUMAN; PANCREAS BLOOD FLOW; PANCREAS ISLET; PORTAL VEIN; PRIORITY JOURNAL; RAT; VAGUS NERVE; ANIMAL; BLOOD; DRUG ANTAGONISM; GLUCOSE TOLERANCE TEST; KIDNEY CIRCULATION; PHYSIOLOGY; SECRETION; SPLANCHNIC BLOOD FLOW; VASCULARIZATION; WISTAR RAT;

ANIMALS; C-PEPTIDE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; INSULIN; ISLETS OF LANGERHANS; MALE; MICROCIRCULATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PEPTIDES; RATS; RATS, WISTAR; RENAL CIRCULATION; SPLANCHNIC CIRCULATION; VENOMS;

EID: 84857072431     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20090464     Document Type: Article

References (32)

1. Sjoholm, A. and Nystrom, T. (2006) Inflammation and the etiology of type 2 diabetes. Diabetes Metab. Res. Rev. 22, 4-10
2. Jansson, L. (1994) The regulation of pancreatic islet blood flow. Diabetes Metab. Rev. 10, 407-416
3. Iwase, M., Sandler, S., Carlsson, P. O., Hellerstrom, C. and Jansson, L. (2001) The pancreatic islets in spontaneously hypertensive rats: islet blood flow and insulin production. Eur. J. Endocrinol. 144, 169-178
4. Svensson, A. M., Ostenson, C. G., Efendic, S. and Jansson, L. (2007) Effects of glucagon-like peptide-1-(7-36)-amide on pancreatic islet and intestinal blood perfusion in Wistar rats and diabetic GK rats. Clin. Sci. 112, 345-351
5. Amori, R., Lau, J. and Pittas, A. (2007) Efficacy and safety of incretin therapy in type 2 diabetes. JAMA, J. Am. Med. Assoc. 198, 194-206
6. Kendall, D. M., Riddle, M. C., Rosenstock, J., Zhuang, D., Kim, D. D., Fineman,M. S. and Baron, A. D. (2005) Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care 28, 1083-1091
7. Fineman, M. S., Bicsak, T. A., Shen, L. Z., Taylor, K., Gaines, E., Varns, A., Kim, D. and Baron, A. D. (2003) Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes. Diabetes Care 26, 2370-2377
8. Garber, A., Henry, R. R., Ratner, R., Hale, P., Chang, C. T. and Bode, B. (2011) Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes. Diabetes Obes. Metab. 13, 348-356
9. Hansen, L., Hartmann, B., Mineo, H. and Holst, J. (2004) Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum. Regul. Pept. 118, 11-18
10. Nystrom, T., Gonon, A. T., Sjoholm, A. and Pernow, J. (2005) Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism. Regul. Pept. 5, 173-177
11. Gardiner, S. M., March, J. E., Kemp, P. A. and Bennett, T. (2006) Mesenteric vasoconstriction and hindquarters vasodilatation accompany the pressor actions of exendin-4 in conscious rats. J. Pharmacol. Exp. Ther. 316, 852-859
12. Ozyazgan, S., Kutluata, N., Afsar, S., Ozdas, S. B. and Akkan, A. G. (2005) Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats. Pharmacology 74, 119-126
13. Cotter, M. A., Ekberg, K., Wahren, J. and Cameron, N. E. (2003) Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition. Diabetes 52, 1812-1817
14. Johansson, B. L., Wahren, J. and Pernow, J. (2003) C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism. Am. J. Physiol. Endocrinol. Metab. 285, E864-E870
15. Nordquist, L., Lai, E. Y., Sjoquist, M., Jansson, L. and Persson, A. E. (2008) C-peptide constricts pancreatic islet arterioles in diabetic, but not normoglycaemic mice. Diabetes Metab. Res. Rev. 24, 165-168
16. Jansson, L. (1995) Effects of C-peptide on splanchnic blood flow in anaesthetized rats. Med. Sci. Res. 23, 7-158
17. Huang, Z. and Sjoholm, A. (2008) Ethanol acutely stimulates islet blood flow, amplifies insulin secretion, and induces hypoglycemia via nitric oxide and vagally mediated mechanisms. Endocrinology 149, 232-236
18. Carlsson, P. O., Olsson, R., Kallskog, O., Bodin, B., Andersson, A. and Jansson, L. (2002) Glucose-induced islet blood flow increase in rats: interaction between nervous and metabolic mediators. Am. J. Physiol. Endocrinol. Metab. 283, E457-E464
19. Burcelin, R., Da Costa, A., Drucker, D. and Thorens, B. (2001) Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes 50, 1720-1728
20. Jansson, L. and Andersson, A. (1997) Nitric oxide and pancreatic islet blood flow after induced portal hypertension in rats. Pancreas 14, 280-284
21. Jansson, L. and Hellerstrom, C. (1983) Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabetologia 25, 45-50
22. Jansson, L. and Hellerstrom, C. (1981) A rapid method of visualizing the pancreatic islets for studies of islet capillary blood flow using non-radioactive microspheres. Acta Physiol. Scand. 113, 371-374
23. Jansson, L. (1988) Glucose stimulation of pancreatic islet blood flow by redistribution of the blood flow within the whole pancreatic gland. Pancreas 3, 409-412
24. Jansson, L. (1984) The blood flow to the pancreas and the islets of Langerhans during an intraperitoneal glucose load in the rat. Diabetes Res. 1, 111-114
25. Golpon, H., Puechner, A., Welter, T.,Wichert, P. and Feddersen, C. (2001) Vasorelaxant effect of glucagon-like peptide (7-36) amide and amylin on the pulmonary circulation of the rat. Regul. Pept. 102, 81-86
26. Baggio, L. L. and Drucker, D. J. (2007) Biology of Incretins: GLP-1 and GIP. Gastroenterology 132, 2131-2157
27. Nathanson, D., Erdogdu, O., Pernow, J., Zhang, Q. and Nystrom, T. (2009) Endothelial dysfunction induced by triglycerides is not restored by exenatide in rat conduit arteries ex vivo. Regul. Pept. 157, 8-13
28. Ban, K., Noyan-Ashraf, M. H., Hoefer, J., Bolz, S. S., Drucker, D. J. and Husain, M. (2008) Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation 117, 2340-2350
29. Sonne, D. P., Engstrom, T. and Treiman, M. (2008) Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart. Regul. Pept. 146, 243-249
30. Hansen, A., Johansson, B. L.,Wahren, J. and Von Bibra, H. (2002) C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes 51, 3077-3082
31. Wallerath, T., Kunt, T., Forst, T., Closs, E. I., Lehmann, R., Flohr, T., Gabriel, M., Schafer, D., Gopfert, A., Pfutzner, A. et al. (2003) Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 9, 95-102
32. Svensson, A. M., Ostenson, C. G., Sandler, S., Efendic, S. and Jansson, L. (1994) Inhibition of nitric oxide synthase by NG-nitro-L-arginine causes a preferential decrease in pancreatic islet blood flow in normal rats and spontaneously diabetic GK rats. Endocrinology 135, 9-853